Asia-Pacific consensus guidelines on gastric cancer prevention (Q37101686)

18 August 2017

title

Asia-Pacific consensus guidelines on gastric cancer prevention (English)

1 reference

18 August 2017

1 reference

Paul Moayyedi

1 reference

18 August 2017

Tsutomu Chiba

1 reference

18 August 2017

Abdul Aziz Rani

1 reference

18 August 2017

Kwong Ming Fock

1 reference

18 August 2017

Nick Talley

1 reference

18 August 2017

Richard Hunt

1 reference

18 August 2017

Takeshi Azuma

1 reference

18 August 2017

Kentaro Sugano

1 reference

18 August 2017

Shu Dong Xiao

1 reference

18 August 2017

Shiu Kum Lam

1 reference

18 August 2017

Khean Lee Goh

1 reference

18 August 2017

Naomi Uemura

1 reference

18 August 2017

Jae G Kim

1 reference

18 August 2017

Nayoung Kim

1 reference

18 August 2017

Tiing Leong Ang

1 reference

18 August 2017

Varocha Mahachai

1 reference

18 August 2017

Hazel Mitchell

1 reference

18 August 2017

Jyh Ming Liou

1 reference

18 August 2017

Ratha-Korn Vilaichone

1 reference

18 August 2017

Jose Sollano

1 reference

18 August 2017

Asia-Pacific Gastric Cancer Consensus Conference

1 reference

18 August 2017

publication date

1 March 2008

1 reference

Journal of Gastroenterology and Hepatology

18 August 2017

published in

1 reference

18 August 2017

1 reference

18 August 2017

1 reference

18 August 2017

page(s)

351-365

1 reference

The future of gastric cancer prevention

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

Survival after surgical treatment of early gastric cancer: surgical techniques and long-term survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

Indications for EMR/ESD in cases of early gastric cancer: relationship between histological type, depth of wall invasion, and lymph node metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

Endoscopic resection of early gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

Screening for gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

Efficacy of screening for gastric cancer in a Korean adult population: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

Prevalence of Helicobacter pylori in asymptomatic population--a pilot serological study in Bangladesh

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

Seroprevalence of Helicobacter pylori infection in urban and rural Vietnam

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

Prevalence of Helicobacter pylori infection in Korean children: inverse relation to socioeconomic status despite a uniformly high prevalence in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

Epidemiology of Helicobacter pylori in Southern China: Identification of Early Childhood as the Critical Period for Acquisition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

Ecological study of association between Helicobacter pylori infection and gastric cancer in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

Racial differences in Helicobacter pylori, serum pepsinogen and gastric cancer incidence in an urban Asian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

The racial cohort phenomenon: seroepidemiology of Helicobacter pylori infection in a multiracial South-East Asian country

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

Ethnicity and H. pylori as risk factors for gastric cancer in Malaysia: A prospective case control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

Circulating anti-Helicobacter pylori immunoglobulin A antibodies and low serum pepsinogen I level are associated with increased risk of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

Differential Helicobacter pylori infection rates in two contrasting gastric cancer risk regions of South China. China Gastric Cancer Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

Helicobacter pylori infection and gastric cancer. A nested case-control study in a rural area of Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

Helicobacter pylori infection and mortality from ischaemic heart disease: negative result from a large, prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

Association between diversity in the Src homology 2 domain--containing tyrosine phosphatase binding site of Helicobacter pylori CagA protein and gastric atrophy and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

Dietary salt, nitrate and stomach cancer mortality in 24 countries. European Cancer Prevention (ECP) and the INTERSALT Cooperative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

Vegetables, fruit and risk of gastric cancer in Japan: a 10-year follow-up of the JPHC Study Cohort I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

Fruit and vegetable consumption and incidence of gastric cancer: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

Fruit and vegetable intake and the risk of stomach and oesophagus adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

Fruit and vegetables consumption and gastric cancer: a systematic review and meta-analysis of cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

Effect of physiological concentrations of vitamin C on gastric cancer cells and Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

Helicobacter pyloriInfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

Inflammation, atrophy, and gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

Interleukin-1 polymorphisms associated with increased risk of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

Interleukin-1 gene polymorphisms and gastric cancer risk in a high-risk Italian population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

Controversy in polymorphisms of interleukin-1beta in gastric cancer risks

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

The -251T allele of the interleukin-8 promoter is associated with increased risk of gastric carcinoma featuring diffuse-type histopathology in Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

Interleukin-8 promoter polymorphism increases the risk of atrophic gastritis and gastric cancer in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

Interleukin-1B gene promoter variants are associated with an increased risk of gastric cancer in a Chinese population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

Association of the interleukin-1 beta genetic polymorphism and gastric cancer risk in Japanese

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

Association of interleukin 1B gene polymorphism and gastric cancers in high and low prevalence regions in China.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

Interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms and gastric cancer: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

Meta-analysis of the relationship between cagA seropositivity and gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

Association of peptic ulcer with increased expression of Lewis antigens but not cagA, iceA, and vacA in Helicobacter pylori isolates in an Asian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

Distribution of Helicobacter pylori cagA, cagE and vacA in different ethnic groups in Kuala Lumpur, Malaysia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

Seroprevalence of cytotoxin-associated gene A positive Helicobacter pylori strains in Changle, an area with very high prevalence of gastric cancer in South China

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

Helicobacter pylori infection and chronic gastric acid hyposecretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

Variation in serum pepsinogens with severity and topography of Helicobacter pylori-associated chronic gastritis in dyspeptic patients referred for endoscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

The epidemiology of low serum pepsinogen A levels and an international association with gastric cancer rates. EUROGAST Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

Serum pepsinogen and gastric cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

Clinical application of serum pepsinogen I and II levels for mass screening to detect gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

Sensitivity and specificity of mass screening for gastric cancer using the measurment of serum pepsinogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

Usefulness of gastric cancer screening using the serum pepsinogen test method

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

Gastric cancer screening using the serum pepsinogen test method

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

Effects of Helicobacter pylori and nonsteroidal anti-inflammatory drugs on peptic ulcer disease: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

A community screening program for Helicobacter pylori saves money: 10-year follow-up of a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

Helicobacter pylori and antimicrobial resistance: molecular mechanisms and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

Consumption of imipenem correlates with beta-lactam resistance in Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

The prevalence of faecal carriage of ampicillin-resistant and high-level gentamicin-resistant enterococci among inpatients at 10 major Norwegian hospitals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

Antibiotic usage and resistance in different regions of the Dutch community

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

Pharmacoepidemiological analysis of provincial differences between consumption of macrolides and rates of erythromycin resistance among Streptococcus pyogenes isolates in Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

European multicentre survey of in vitro antimicrobial resistance in Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

The relationship between consumption of antimicrobial agents and the prevalence of primary Helicobacter pylori resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

Kylie Minogue's breast cancer: effects on referrals to a rapid access breast clinic in the UK

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

Impact of Helicobacter pylori eradication on heartburn in patients with gastric or duodenal ulcer disease -- results from a randomized trial programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

Helicobacter pylori eradication does not exacerbate reflux symptoms in gastroesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

Helicobacter pylori and symptomatic relapse of gastro-oesophageal reflux disease: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

Effect of Helicobacter pylori eradication on oesophageal acid exposure in patients with reflux oesophagitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

Effect of Helicobacter pylori eradication on development of dyspeptic and reflux disease in healthy asymptomatic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

Effect of population screening and treatment for Helicobacter pylori on dyspepsia and quality of life in the community: a randomised controlled trial. Leeds HELP Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

The significance of cagA(+) Helicobacter pylori in reflux oesophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

Role of Helicobacter pylori CagA+ strains and risk of adenocarcinoma of the stomach and esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

Long term follow up of patients treated for Helicobacter pylori infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

Helicobacter pylori infection and the development of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

Colonic amoebiasis and spirochetosis: morphological, ultrastructural and microbiological evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

Recrudescence and reinfection with Helicobacter pylori after eradication therapy in Bangladeshi adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

Review article: Overview of medical treatments in unresectable hepatocellular carcinoma--an impossible meta-analysis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

Does the Method of Helicobacter pylori Detection Influence the Association with Gastric Cancer Risk?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

Chemoprevention of Precancerous Gastric Lesions With Antioxidant Vitamin Supplementation: A Randomized Trial in a High-Risk Population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05314.X

Eradication of Helicobacter pylori for non-ulcer dyspepsia

21 January 2018

1 reference

COCI

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD002096.PUB4

10.1111/J.1440-1746.2008.05314.X

12 January 2024

Identifiers

DOI

1 reference

18 August 2017

1 reference